Back
Structure Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
GPCR
Structure Therapeutics, Inc.
Last Price:
$71.39
Seasonality Move:
-34.19%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
Structure Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.95 | Sell |
| 20-day SMA: | 51.13 | Buy |
| 50-day SMA: | 39.46 | Buy |
| 200-day SMA: | 25.84 | Buy |
| 8-day EMA: | 61.92 | Buy |
| 20-day EMA: | 54.26 | Buy |
| 50-day EMA: | 43.12 | Buy |
| 200-day EMA: | 30.85 | Buy |
Structure Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.16 | Buy |
| Relative Strength Index (14 RSI): | 66.95 | Buy |
| Chaikin Money Flow: | -399152 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.54 - 63.42) | Buy |
| Bollinger Bands (100): | (16.99 - 44.17) | Buy |
Structure Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics, Inc. Stock
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 63.25 while GPCR 8-day simple moving average is 63.95, which is a Sell signal.
-
The stock price of GPCR is 63.25 while Structure Therapeutics, Inc. 20-day SMA is 51.13, which makes it a Buy.
-
Structure Therapeutics, Inc. 50-day simple moving average is 39.46 while GPCR share price is 63.25, making it a Buy technically.
-
GPCR stock price is 63.25 and Structure Therapeutics, Inc. 200-day simple moving average is 25.84, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Buy
56
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy or a Sell?
-
Structure Therapeutics, Inc. stock is rated a BuyThe current Structure Therapeutics, Inc. [GPCR] share price is $63.25. The Score for GPCR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Structure Therapeutics, Inc. Stock Info
Market Cap:
3.6B
Price in USD:
63.25
Share Volume:
1.4M
Structure Therapeutics, Inc. 52-Week Range
52-Week High:
94.90
52-Week Low:
13.22
Buy
56
Structure Therapeutics, Inc. (GPCR)
is a Buy
Structure Therapeutics, Inc. Share Price Forecast
-
What is the Structure Therapeutics, Inc. stock price today?The Structure Therapeutics, Inc. stock price is 63.25 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics, Inc. is not overvalued.
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 63.25 while GPCR 8-day exponential moving average is 61.92, which is a Buy signal.
-
The stock price of GPCR is 63.25 while Structure Therapeutics, Inc. 20-day EMA is 54.26, which makes it a Buy.
-
Structure Therapeutics, Inc. 50-day exponential moving average is 43.12 while GPCR share price is 63.25, making it a Buy technically.
-
GPCR stock price is 63.25 and Structure Therapeutics, Inc. 200-day simple moving average is 30.85, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics, Inc.
Is Structure Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Structure Therapeutics, Inc.
Should I short Structure Therapeutics, Inc. stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 8.16, suggesting Structure Therapeutics, Inc. is a Buy
-
Structure Therapeutics, Inc. Relative Strength Index (RSI) is 66.95, which suggest Structure Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Structure Therapeutics, Inc. is (32.54 - 63.42), which suggest Structure Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Structure Therapeutics, Inc. is (16.99 - 44.17), which suggest Structure Therapeutics, Inc. is a Buy
* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.